LLANFYLLIN GROUP PRACTICE
HIGH STREET, LLANFYLLIN
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 152 | 168 | 90.5% | |
| CKD 4 | 2008 | 260 | 293 | 88.7% | |
| CKD 5 | 2009 | 15 | 17 | 88.2% | |
| CKD 5 | 2010 | 56 | 66 | 84.8% | |
| CKD 5 | 2011 | 81 | 93 | 87.1% | |
| CKD 5 | 2012 | 75 | 85 | 88.2% | |
| CKD 5 | 2013 | 68 | 81 | 84.0% | |
| CKD003W | 2014 | 72 | 81 | 88.9% |
